ANIK - Anika Therapeutics, Inc.
14.69
0.180 1.225%
Share volume: 37,544
Last Updated: 04-29-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$14.51
0.18
0.01%
Fundamental analysis
27%
Profitability
1%
Dept financing
11%
Liquidity
74%
Performance
45%
Performance
5 Days
1.80%
1 Month
-2.26%
3 Months
-14.99%
6 Months
-40.48%
1 Year
-43.26%
2 Year
-43.50%
Key data
Stock price
$14.69
DAY RANGE
$14.37 - $14.74
52 WEEK RANGE
$12.83 - $29.12
52 WEEK CHANGE
-$44.55
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
Company detail
CEO: Cheryl R. Blanchard
Region: US
Website: anikatherapeutics.com
Employees: 300
IPO year: 1993
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: anikatherapeutics.com
Employees: 300
IPO year: 1993
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Anika Therapeutics, Inc. creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform.
Recent news
